BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29734534)

  • 1. The genetic background of climacteric symptoms in women during menopause.
    Slopień R; Rózycka A; Slopień A; Pawlak M; Warenik-Szymankiewicz A; Sajdak S; Jagodziński P
    Clin Exp Obstet Gynecol; 2016; 43(4):495-499. PubMed ID: 29734534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women.
    Różycka A; Słopień R; Słopień A; Dorszewska J; Seremak-Mrozikiewicz A; Lianeri M; Maciukiewicz M; Warenik-Szymankiewicz A; Grzelak T; Kurzawińska G; Drews K; Klejewski A; Jagodziński PP
    Maturitas; 2016 Feb; 84():42-54. PubMed ID: 26620113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin concentration and severity of depression symptoms in climacteric women.
    Słopień R; Słopień A; Warenik-Szymankiewicz A
    Clin Exp Obstet Gynecol; 2015; 42(6):749-51. PubMed ID: 26753478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms and hormonal profile in climacteric women.
    Słopień R; Słopień A; Warenik-Szymankiewicz A; Sajdak S
    Clin Exp Obstet Gynecol; 2015; 42(3):285-91. PubMed ID: 26151994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5HTT and MAO-A polymorphisms associate with depressive mood and climacteric symptoms in postmenopausal women.
    Grochans E; Grzywacz A; Jurczak A; Samochowiec A; Karakiewicz B; Brodowska A; Starczewski A; Samochowiec J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():125-30. PubMed ID: 23707423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland.
    Słopien R; Jasniewicz K; Meczekalski B; Warenik-Szymankiewicz A; Lianeri M; Jagodziński PP
    Maturitas; 2008 Nov; 61(3):252-5. PubMed ID: 18801628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbances of sleep continuity in women during the menopausal transition.
    Słopień R; Wichniak A; Pawlak M; Słopień A; Warenik-Szymankiewicz A; Sajdak S
    Psychiatr Pol; 2015; 49(3):615-23. PubMed ID: 26276926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in the MTHFD1 gene increases a mother's risk of having an unexplained second trimester pregnancy loss.
    Parle-McDermott A; Pangilinan F; Mills JL; Signore CC; Molloy AM; Cotter A; Conley M; Cox C; Kirke PN; Scott JM; Brody LC
    Mol Hum Reprod; 2005 Jul; 11(7):477-80. PubMed ID: 16123074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The c.1460C>T polymorphism of MAO-A is associated with the risk of depression in postmenopausal women.
    Słopień R; Słopień A; Różycka A; Warenik-Szymankiewicz A; Lianeri M; Jagodziński PP
    ScientificWorldJournal; 2012; 2012():194845. PubMed ID: 22619623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of the MTHFD1 (rs2236225), eNOS (rs1799983), CBS (rs2850144) and ACE (rs4343) gene polymorphisms in a population of Iranian pediatric patients with congenital heart defects.
    Khatami M; Ratki FM; Tajfar S; Akrami F
    Kaohsiung J Med Sci; 2017 Sep; 33(9):442-448. PubMed ID: 28865601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
    Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between climacteric symptoms and serum levels of estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone.
    Abe T; Furuhashi N; Yamaya Y; Wada Y; Hoshiai A; Suzuki M
    Am J Obstet Gynecol; 1977 Sep; 129(1):65-7. PubMed ID: 900171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between SNPs and hepatotoxicity in patients with primary central nervous system lymphoma on high-dose methotrexate therapy.
    Zhao Q; Cui Y; Zeng C; Ren X; Yu K; Lin S; Zhao Z; Mei S
    J Pharm Pharmacol; 2021 Oct; 73(11):1480-1490. PubMed ID: 34254644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment of the relationship between personality, the presence of the 5HTT and MAO-A polymorphisms, and the severity of climacteric and depressive symptoms in postmenopausal women.
    Jurczak A; Szkup M; Wieder-Huszla S; Grzywacz A; Samochowiec A; Karakiewicz B; Samochowiec J; Grochans E
    Arch Womens Ment Health; 2015 Aug; 18(4):613-21. PubMed ID: 25655492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [G894T (NOS3) and G1958A (MTHFD1) gene polymorphisms and risk of ischemic heart disease in Yucatan, Mexico].
    García-González I; Solís-Cárdenas Ade J; Flores-Ocampo JA; Alejos-Mex R; Herrera-Sánchez LF; González-Herrera LJ
    Clin Investig Arterioscler; 2015; 27(2):64-73. PubMed ID: 25304051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden.
    Ali M; Lemonakis K; Wihlborg AK; Veskovski L; Turesson I; Mellqvist UH; Gullberg U; Hansson M; Nilsson B
    Blood Cancer J; 2019 Jul; 9(8):57. PubMed ID: 31363079
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patients.
    Palmer BR; Slow S; Ellis KL; Pilbrow AP; Skelton L; Frampton CM; Palmer SC; Troughton RW; Yandle TG; Doughty RN; Whalley GA; Lever M; George PM; Chambers ST; Ellis C; Richards AM; Cameron VA
    PLoS One; 2014; 9(3):e89029. PubMed ID: 24618918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between climacteric symptoms and serum neuropeptide Y level in postmenopausal women].
    Słopień R; Meczekalski B; Warenik-Szymankiewicz A
    Ginekol Pol; 2003 Sep; 74(9):1023-8. PubMed ID: 14674163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between allopregnanolone levels and depressive symptoms during late menopausal transition and early postmenopause.
    Slopien R; Pluchino N; Warenik-Szymankiewicz A; Sajdak S; Luisi M; Drakopoulos P; Genazzani AR
    Gynecol Endocrinol; 2018 Feb; 34(2):144-147. PubMed ID: 28857628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.